The Oregon Psychedelic Industry Begins

With the regulatory framework of Measure 109 now in place, the start of 2023 means that Oregon is beginning to accept applications for licenses to operate in the new psychedelic industry.

The Oregon Health Authority Public Health Division's Center for Health Protection now houses a new division called Oregon Psilocybin Services. Ballot Measure 109, passed in November 2020, instructs the Oregon Health Authority to license and regulate the production, transportation, distribution, sale, and purchase of psilocybin items as well as the supply of psilocybin services. Starting on January 2, 2023, license applications will be accepted by the Oregon Psilocybin Services Section.Manufacturers, service providers, testing facilities, and facilitators all need licenses to work with psychedelics and provide services to the new patient seeking alternative therapy treatments. According to data gathered by SykoActive, the Oregon Health Authority has only received three manufacturer license applications and forty labor permit applications as of Wednesday.

What are psilocybin services?

In Oregon, “psilocybin services” refers to preparation, administration and integration sessions provided by a licensed facilitator. The psilocybin products consumed must be cultivated or produced by a licensed psilocybin manufacturer and may only be provided to a client at a licensed psilocybin service center during an administration session. Psilocybin services will be available to people age 21 or older and will not require a prescription or medical referral. People accessing psilocybin services are called “clients”.

To Learn More Visit The Oregon Health Authority Website



SykoActive

Graham Krutch, also known as 'Gram Kracker,' is the founder and CEO of SykoActive Non-Profit Association, boasting over two decades of experience in the industry of medicinal plants and psychedelic substances. His expertise extends from cultivation to patient consultation, primarily focusing on cannabis and psilocybin, alongside notable advancements in the hemp and CBD sector.

Under Graham's guidance, SykoActive investigates and advocates for the therapeutic uses of psychedelic plant medicines. He is committed to informing the public about secure alternative treatments and tackling the worldwide mental health dilemma.

Beyond his involvement in the psychedelic realm, Graham possesses a varied skill set in event marketing and product management. His efforts have been instrumental in the prosperity of leading convenience stores, and he shines in team leadership, strategic planning, and project management. As a fervent proponent of Applied AI Science and proficient in AI research and technological tools, he adeptly merges a customer-centric approach with an acute awareness of time constraints.

https://www.sykoactive.com
Previous
Previous

Elon Musk's Neuralink Secures FDA Approval for Human Brain Implant Study

Next
Next

Psychedelic Therapies Included In Your Employee Benefits